Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus

被引:34
作者
De Silvestri, A
Pasi, A
Martinetti, M
Belloni, C
Tinelli, C
Rondini, G
Salvaneschi, L
Cuccia, M
机构
[1] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, Unita Biometria, I-27100 Pavia, Italy
[3] Policlin San Matteo, IRCCS, Serv Immunoematol & Trasfus, I-27100 Pavia, Italy
[4] Policlin San Matteo, IRCCS, Ctr Immunol Trapianto, I-27100 Pavia, Italy
[5] Policlin San Matteo, IRCCS, Div Neonatol & Terapia Intens, I-27100 Pavia, Italy
关键词
family study; anti-hepatitis B vaccination; fourth component of complement;
D O I
10.1038/sj.gene.6363792
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-responsiveness to hepatitis B virus (HBV) vaccine in adults is strongly associated with HLA-C4AQ0,DRB1* 0301,DQB1 *02 haplotype. This association was also demonstrated in neonates who failed to mount a humoral response to challenge with HBV vaccine. About 4% of vaccinated newborns do not reach a protective antibody level (greater than or equal to 10 mlU/ml) at seroconversion and 0.4% is a non-responder even after receiving a fourth dose of vaccine (true non-responders (TNR)); while 3.6% achieved an antibody level greater than or equal to 10 mlU/ml (slow responders (SR)) only when reboostered with the fourth dose. In the present study we extend the vaccination and HLA typing to 91 family members of probands to understand better the possible parent-to-child transmission of this trait. A transmission disequilibrium test (TDT), performed in 27 families, showed that the C4AQ0 allele was almost always transmitted to probands, both TNRs and SRs. Although not statistically significant, the highest LOD score was obtained with C4A locus: 1.58. These results suggest the presence of a region regulating immune response against HBV vaccination near to or coincident with the C4A locus.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 15 条
  • [1] Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine
    Belloni, C
    Tinelli, C
    Orsolini, P
    Pistorio, A
    Avanzini, A
    Moretta, A
    Gulminetti, R
    Bogliolo, O
    Chirico, G
    Rondini, G
    [J]. VACCINE, 1998, 16 (04) : 399 - 402
  • [2] Complement and the immune response
    Carroll, MC
    Fischer, MB
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 64 - 69
  • [3] Response to hepatitis B vaccine: multiple HLA genes are involved
    Desombere, I
    Willems, A
    Leroux-Roels, G
    [J]. TISSUE ANTIGENS, 1998, 51 (06): : 593 - 604
  • [4] STRUCTURAL DIFFERENCES BETWEEN THE 2 HUMAN-COMPLEMENT C4 ISOTYPES AFFECT THE HUMORAL IMMUNE-RESPONSE
    FINCO, O
    LI, SL
    CUCCIA, M
    ROSEN, FS
    CARROLL, MC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 537 - 543
  • [5] FISHER MB, 1996, J IMMUNOL, V157, P549
  • [6] THE IMMUNE-RESPONSE TO HEPATITIS-B VACCINE IN HUMANS - INHERITANCE PATTERNS IN FAMILIES
    KRUSKALL, MS
    ALPER, CA
    AWDEH, Z
    YUNIS, EJ
    MARCUSBAGLEY, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 495 - 502
  • [7] LATHROP GM, 1984, P NATL ACAD SCI USA, V81, P3433
  • [8] Humoral response to recombinant hepatitis B virus vaccine at birth: Role of HLA and beyond
    Martinetti, M
    De Silvestri, A
    Belloni, C
    Pasi, A
    Tinelli, C
    Pistorio, A
    Salvaneschi, L
    Rondini, G
    Avanzini, MA
    Cuccia, M
    [J]. CLINICAL IMMUNOLOGY, 2000, 97 (03) : 234 - 240
  • [9] ANTI-HBV NEONATAL IMMUNIZATION WITH RECOMBINANT VACCINE .2. MOLECULAR-BASIS OF THE IMPAIRED ALLOREACTIVITY
    MARTINETTI, M
    CUCCIA, M
    DAIELLI, C
    AMBROSELLI, F
    GATTI, C
    PIZZOCHERO, C
    BELLONI, C
    ORSOLINI, P
    SALVANESCHI, L
    [J]. VACCINE, 1995, 13 (06) : 555 - 560
  • [10] Reference typing report for complement component C4
    Mauff, G
    Luther, B
    Schneider, PM
    Rittner, C
    Stradmann-Bellinghausen, B
    Dawkins, R
    Moulds, JM
    [J]. EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1998, 15 (04) : 249 - 260